Gene · 3036
Papers4,320
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,320
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer. | Nature | 2023 | 37532934 | PubTator, text mining | PubMed |
| Proregenerative extracellular matrix hydrogel mitigates pathological alterations of pelvic skeletal muscles after birth injury. | Sci Transl Med | 2023 | 37531414 | PubTator, text mining | PubMed |
| Protective effects of red orange (Citrus sinensis [L.] Osbeck [Rutaceae]) extract against UVA-B radiation-induced photoaging in Skh:HR-2 mice. | Nutr Res Pract | 2023 | 37529272 | PubTator, text mining | PubMed |
| Imaging supermolecular interactions of the pharmaceutical-cocrystal of apigenin-nicotinamide binding with serum albumin. | Turk J Chem | 2023 | 37529220 | PubTator, text mining | PubMed |
| A postnatal network of co-hepato/pancreatic stem/progenitors in the biliary trees of pigs and humans. | NPJ Regen Med | 2023 | 37528116 | PubTator, text mining | PubMed |
| Dermal fibroblast cell-derived exosomes for atopic dermatitis: In-vitro test. | Skin Res Technol | 2023 | 37522488 | PubTator, text mining | PubMed |
| Protein-Templated Metal Nanoclusters: Molecular-like Hybrids for Biosensing, Diagnostics and Pharmaceutics. | Molecules | 2023 | 37513403 | PubTator, text mining | PubMed |
| Chondrocyte Homeostasis and Differentiation: Transcriptional Control and Signaling in Healthy and Osteoarthritic Conditions. | Life (Basel) | 2023 | 37511835 | PubTator, text mining | PubMed |
| Safety and Healthcare Resource Utilization in Patients Undergoing Left Atrial Appendage Closure-A Nationwide Analysis. | J Clin Med | 2023 | 37510689 | PubTator, text mining | PubMed |
| Alternative Splicing, RNA Editing, and the Current Limits of Next Generation Sequencing. | Genes (Basel) | 2023 | 37510291 | PubTator, text mining | PubMed |
| CD44 Is Associated with Poor Prognosis of ccRCC and Facilitates ccRCC Cell Migration and Invasion through HAS1/MMP9. | Biomedicines | 2023 | 37509716 | PubTator, text mining | PubMed |
| Has-miR-129-5p's Involvement in Different Disorders, from Digestive Cancer to Neurodegenerative Diseases. | Biomedicines | 2023 | 37509697 | PubTator, text mining | PubMed |
| Antioxidant Effects of Catechins (EGCG), Andrographolide, and Curcuminoids Compounds for Skin Protection, Cosmetics, and Dermatological Uses: An Update. | Antioxidants (Basel) | 2023 | 37507856 | PubTator, text mining | PubMed |
| Effects of Plant-Derived Dietary Supplements on Skin Health: A Review. | Cureus | 2023 | 37492817 | PubTator, text mining | PubMed |
| Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemia. | Front Oncol | 2023 | 37476380 | PubTator, text mining | PubMed |
| Super Enhancer Driven Hyaluronan Synthase 3 Promotes Malignant Progression of Nasopharyngeal Carcinoma. | J Cancer | 2023 | 37476195 | PubTator, text mining | PubMed |
| Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. | Cancer Res Commun | 2023 | 37476073 | PubTator, text mining | PubMed |
| Contemporary human H3N2 influenza A viruses require a low threshold of suitable glycan receptors for efficient infection. | Glycobiology | 2023 | 37471650 | PubTator, text mining | PubMed |
| The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes. | J Clin Invest | 2023 | 37471144 | PubTator, text mining | PubMed |
| Establishing haptic texture attribute space and predicting haptic attributes from image features using 1D-CNN. | Sci Rep | 2023 | 37468571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3036/papers?page=18